Recruiting

Continuous Glucose Monitoring

Sponsor:

Icahn School of Medicine at Mount Sinai

Code:

NCT07174245

Conditions

Gestational Diabetes

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

continuous glucose monitor

Study Details

Brief summary:

Gestational diabetes (GDM) is one of the most common complications of pregnancy, and up to one third of women with GDM will have abnormal blood sugars after their pregnancy. To screen for abnormal blood sugars, standard of care is a 4-12 week postpartum oral glucose tolerance test (OGTT). However only 17-60% of women actually have this test performed. This study is to assess continuous glucose monitor data from the third trimester and up to 14 days postpartum to find predictors of postpartum OGTT results.

Conditions

Gestational Diabetes

Study ID

NCT07174245

Start date

Aug 5, 2025

Status verified date

Jul, 2026

Completion date

Jul 1, 2027

Anticipated

Primary completion date

Jul 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of gestational diabetes during current pregnancy
  • age 18 or older
  • prescribed Dexcom G7

Exclusion Criteria:

  • Pregestational diabetes
  • known skin adhesive allergy which inhibits ongoing use of CGM
  • chronic oral steroid use.

Study Design

Enrollment

40 participants

Anticipated

Interventions and Outcome Measures

Arms

Participants with Gestational diabetes GDM

All participants who wear CGM and have their postpartum OGTT

Interventions

continuous glucose monitor

All participants who wear CGM

Primary outcome measure

  • Sensitivity of postpartum TIR <96% [ Time Frame: up to 12 weeks postpartum ]

Central Contacts and Locations

Central contacts

Sarah Rancic

212-241-5355sarah.rancic@mssm.edu

Grenye O'Malley

212-241-7173grenye.o'malley@mssm.edu

Locations

Icahn School of Medicine at Mount Sinai

Recruiting

New York, New York, United States, 10029

Contacts

Sarah Rancic

212-241-5355sarah.rancic@mssm.edu

Principal Investigator:

Grenye O'Malley

More Information

Sponsor

Icahn School of Medicine at Mount Sinai

Last update posted

Jul 8, 2026

Last verified

Jul, 2026

Keywords

  • gestational diabetes
  • continuous glucose monitor
  • glucose sensor
  • oral glucose tolerance test

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-25. This information was provided to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai on 2026-07-08. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.